Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.71%
#3 Ankr Network Ankr Network +22.53%
#4 BankrCoin BankrCoin +21.15%
#5 Pons Pons +13.39%
#6 Status Status +12.03%
#7 Provenance Blockchain Provenance Blockchain +9.12%
#8 Hive Hive +9.05%
#9 Prom Prom +7.77%
#10 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.76%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
Guangzhou Innogen Pharmaceutl Grp Co Ltd Guangzhou Innogen Pharmaceutl Grp Co Ltd

Guangzhou Innogen Pharmaceutl Grp Co Ltd

2591
Rank in Stocks #18331
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based... Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Share Price
$0.44518328
Market Cap
$203.37M
Change (1 day)
-2.11%
Change (1 year)
-91.76%
Country
CN
Trade Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)

Category

Healthcare
Earnings for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)
Earnings in 2026 TTM: 0
According to Guangzhou Innogen Pharmaceutl Grp Co Ltd latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Guangzhou Innogen Pharmaceutl Grp Co Ltd from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH